<DOC>
	<DOCNO>NCT02010333</DOCNO>
	<brief_summary>The primary purpose study evaluate safety tolerability single application Ha44 Gel 0.74 % w/w treatment head louse . Secondary purpose evaluate PK Ha44 benzyl alcohol condition maximal exposure pediatric population .</brief_summary>
	<brief_title>A Pediatric Safety Pharmacokinetics Study Ha44 Gel Administered Topically Treatment Head Lice Infestation</brief_title>
	<detailed_description />
	<mesh_term>Parasitic Diseases</mesh_term>
	<mesh_term>Lice Infestations</mesh_term>
	<criteria>1 . Male female , 6months &lt; 3years age 2 . Good health 3 . Active head louse infestation define presence least 3 live louse 4 . Dermatological condition scalp ( least G2 erythema pruritus evidence excoriation/inflammation ) 5 . Parent/guardian agree allow PK sample collect 6 . Signed Informed Consent Form 1 . Condition illness opinion investigator may interfere study result . 2 . Current dermatological disease may compromise health subject assessment safety . Subjects scalp ulceration evidence scalp infection enrol . 3 . Prior reaction product contain piperonyl butoxide , pyrethrin , pyrethrum extract . 4 . Receiving systemic topical medication may interfere study result . 5 . Received investigational agent within 30 day prior Day 0 .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>